Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims
By Hailey Konnath · January 9, 2026, 11:13 PM EST
A Connecticut federal judge on Friday refused to hand a quick win to Mylan Pharmaceuticals and Aurobindo Pharma USA in sprawling antitrust litigation against 26 total pharmaceutical companies, ruling that a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login